 Bristol-Myers Squibb Co NYSE:BMY Q3 2022 Earnings Conference Call October 26, 2022 8:00 AM ET Company Participants Timothy Power - VP Head, IR Giovanni Caforio - Chairman CEO David Elkins - EVP CFO Christopher Boerner - EVP Chief Commercialization Officer Samit Hirawat - EVP Chief Medical Officer, Global Drug Development Conference Call Participants Giovanni Caforio - Chairman CEO Seamus Fernandez - Guggenheim Securities Andrew Baum - Citigroup Robyn Karnauskas - Truist Securities Stephen Scala - Cowen and Company Carter Gould - Barclays Bank Luisa Hector - Berenberg Terence Flynn - Morgan Stanley Timothy Anderson - Wolfe Research Christopher Schott - JPMorgan Chase Co. Matthew Phipps - William Blair Company Chris Shibutani - Goldman Sachs Group Colin Bristow - UBS Mohit Bansal - Wells Fargo Securities Dane Leone - Raymond James Associates Evan Seigerman - BMO Capital Markets Operator Good day, and welcome to the Bristol-Myers Squibb Third Quarter Results Conference Call. Todays conference is being recorded. 